Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
I형 인터페론 자가항체는 COVID-19 환자의 전신 면역 변화와 관련이 있습니다
Research Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
alteration
antibodies
autoantibodies
autoantibody
caused
change
circulating leukocyte
circulating leukocytes
Control
coronavirus
coronavirus disease
Coronavirus disease 2019
correlated
Course
COVID-19
Critical
Critical disease
dendritic cell
description
diagnosed
disease course
disease pathogenesis
Effect
elevated
epitope
evaluated
Evidence
evidence of
expressed
expression
functional
healthy controls
help
IFNs
immune
immune system
Immunoglobulin
in some
increased expression
individual
individuals with COVID-19
inhibitory receptor
interferon
interferon response
interferons
ISG
lack
LAIR1
leukocyte
leukocytes
longitudinal
mechanisms
moderate disease
monocyte
Monocytes
mononuclear cell
mononuclear cells
myeloid cell
myeloid cells
Patient
patients with COVID-19
Peripheral blood
Peripheral blood mononuclear cells
peripheral blood samples
Population
Prevalence
producing
receptor
reduced
respiratory
response
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
Severe case
severe cases
severe disease
severity
single-cell
Single-cell transcriptomics
subset
Support
systemic impact
systemic impacts
the disease
Transcriptome
transcriptome sequencing
transcriptomics
turn
Type
type I
Type I IFN
type I interferon
type I interferons
[DOI] 10.1126/scitranslmed.abh2624 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1126/scitranslmed.abh2624 PMC 바로가기 [Article Type] Research Article